Our latest Study just went online:

Comparative Analysis Between Olink-PEA and Alamar-NULISA Proteomic Technologies Applied to a Critically Ill COVID-19 Cohort

https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/pmic.202400456